EDITORIAL article
Front. Pharmacol.
Sec. Pharmacology of Anti-Cancer Drugs
This article is part of the Research TopicInnovative Strategies for Overcoming Resistance in Tumor Angiogenesis TherapiesView all 8 articles
Editorial: Innovative Strategies for Overcoming Resistance in Tumour Angiogenesis Therapies
Provisionally accepted
- 1University of Pretoria, Pretoria, South Africa
- 2Instituto Nacional de Cancerologia, Mexico City, Mexico
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
cohort. The authors call for the development of predictive biomarkers and novel drug combinations to further enhance outcomes.In conclusion, the contributions to this Special Topic section underscore the dynamic and multifaceted nature of resistance to tumour angiogenesis therapies. By identifying new molecular targets, validating innovative combination therapies, and emphasising the significance of patient stratification, these studies provide guidance for developing more effective and sustainable antiangiogenic strategies. Overcoming resistance will require continued collaboration across disciplines, integration of emerging scientific insights, and a steadfast commitment to patient-centred care.
Keywords: Anti-angiogenic targeted therapy, biomarkers, Cancer, Drug Resistance, tumor angiogenesis
Received: 02 Feb 2026; Accepted: 16 Feb 2026.
Copyright: © 2026 Mabeta, Steenkamp and Díaz-Chávez. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Peace Mabeta
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.